Benzinga | Nov 4, 2020 05:01PM EST

Aquestive Therapeutics Q3 EPS $(0.49) Misses $(0.46) Estimate, Sales $8.30M Miss $8.72M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 9.26 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $8.30 million which missed the analyst consensus estimate of $8.72 million by 4.82 percent. This is a 33.16 percent decrease over sales of $12.42 million the same period last year.